The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
about
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab eraPeripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T.An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy.Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphomaPrognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.Multiple courses of immunotherapy with different immune cell types for patients with hepatocellular carcinoma after microwave ablation.Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent RegimensPositive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinomaPrognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study.Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.The accumulation of macrophages attenuates the effect of recombinant human endostatin on lung cancerA large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era.CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.Role of Monocyte Count and Neutrophil-to-Lymphocyte Ratio in Survival of Oral Cancer Patients.Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.Local and systemic immunity predict survival in patients with pulmonary sarcomatoid carcinoma.Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation.Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism.Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma.Lymphocyte/Monocyte Ratio is a Novel Predictor for Early Stage Extranodal Natural Killer/T-cell Lymphoma, Nasal TypeThe lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy.Should the cut-off values of the lymphocyte to monocyte ratio for prediction of prognosis in diffuse large B-cell lymphoma be changed in elderly patients?Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer.The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study.The Lymphocyte-Monocyte Ratio and the Platelet-Lymphocyte Ratio at Diagnosis as Independent Prognostic Factors in Primary Gastrointestinal Diffuse Large B Cell Lymphoma.Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
P2860
Q30449589-4052A9ED-2901-489F-955D-AF039D289EFFQ33558130-500047F4-D28F-47B1-B810-2D2B4C751E8CQ33662640-290DE7DA-5B00-4557-B292-54C54B0D2E32Q34281919-2C4714F7-90BC-44A3-8F60-166DEC4A970CQ34289239-D47E739D-1995-4BAD-9F9F-9FF2D7599285Q34457064-8309AE8B-3439-4AB4-861B-CFF4B19DE240Q34798062-33B2BEC3-68E2-4895-AC75-820790FE0B61Q36050510-7EC5EC8A-B41E-48F2-8B09-9E60C4F6A4A6Q36081479-9252D46A-FF6F-478A-977C-F3136CF1BE88Q36121167-B2C3B423-70FE-4219-A3B3-28B6E77C3034Q36138851-B25CE895-20AF-4DDB-BE20-9584DB5DA371Q36290407-8982C0A3-E0B6-4C13-9F2D-F50244FD5F80Q36540944-EA2DC22C-063F-464C-A9D7-1AE8BEEE6894Q36673451-098EA433-DA3D-447B-9D0D-E69F24F99D14Q37064572-6ADF466D-B9CC-4A94-91C3-90F911B16D68Q37226075-9AFDC163-3710-4F04-B6E8-F1981E05D0BDQ37297662-310860D9-A094-476E-AA70-9528A585CC3FQ37362567-746540CD-7E99-433C-944C-03D175D3EDFFQ37381494-C81F1E77-3FF8-4D2E-B3E7-1643AE20EFBCQ37416557-B117C656-364B-47FB-9C5D-5F8AF086CDCFQ37487600-4CB499C7-1AB6-43C4-994A-3D3117A1635CQ37529430-0F6F16A4-DCA3-4922-A30A-CE6E3E71ADCAQ37548729-96FE2C56-1F87-4D75-B1FC-79CD5310CC39Q37706368-BEF68550-8D59-410D-839A-D6EF2D11B52FQ38677232-353BC82E-C6A5-49D2-8922-74A559AF13B1Q39150349-8C3D0968-1988-4B40-8EED-33C0DB04DE71Q40288309-3ED1C608-AC70-44D4-A55B-7F8F173B2F2FQ40752311-88ECAB36-8610-4591-B040-6F3C04C3C1F8Q41002912-0012389D-918E-46BC-A44D-67C8736D95C6Q41080159-F1899D52-17AD-4FD6-A9FD-5DB8DE21836BQ42122477-A78111B7-16AB-4ED9-883D-F0D0731CCB06Q42161730-87476B4A-9447-4278-AA4C-8005AD54E89AQ43754838-BD1709F4-3F59-4A7A-A0C3-EF74FDC1E141Q44404015-D6D9EE12-DE14-4C74-9BB3-9F8335E20F44Q45216334-D55241B0-5913-410D-8DE6-39715100D692Q45226424-376F0861-43DD-41B3-9DB8-C18D6578CE73Q45287423-3C88B3BF-D6CC-42AF-8B1B-5056D6CFDA1DQ47108972-174CE93F-85CE-408F-AC82-F3F2A9493E6EQ48212629-204C5FBF-B767-40E9-A521-6DE978ACB752Q48890938-43329D1D-AD0A-491A-9F7F-A829DC3C9BB7
P2860
The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The ratio of the absolute lymp ...... tumor-associated macrophages.
@ast
The ratio of the absolute lymp ...... tumor-associated macrophages.
@en
type
label
The ratio of the absolute lymp ...... tumor-associated macrophages.
@ast
The ratio of the absolute lymp ...... tumor-associated macrophages.
@en
prefLabel
The ratio of the absolute lymp ...... tumor-associated macrophages.
@ast
The ratio of the absolute lymp ...... tumor-associated macrophages.
@en
P2093
P2860
P1433
P1476
The ratio of the absolute lymp ...... tumor-associated macrophages.
@en
P2093
Chansik Park
Cheolwon Suh
Chul-Woo Kim
Dok Hyun Yoon
Heounjeong Go
Hyo Jeong Kang
Ji Eun Kim
Jooryung Huh
Young Wha Koh
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0034
P577
2012-05-15T00:00:00Z